Analytical Data
-
基因名
LDBPK_361420
- Application
-
别名
/
-
种属
Leishmania donovani
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
E9BTK1
-
表达区间
15-98aa
-
分子量
13.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LDBPK_361420 is a recombinant protein derived from the pathogen Leptospira interrogans, the causative agent of leptospirosis, a disease with significant public health implications in many regions of the world. This protein has gained attention due to its potential role in the immune response and pathogenesis of the bacteria. Previous studies have highlighted the importance of exploring recombinant proteins for vaccine development, as they can elicit specific immune responses without the risks associated with live pathogens. The research surrounding LDBPK_361420 aims to elucidate its structure, function, and interactions within the host immune system. By understanding these aspects, scientists hope to develop effective diagnostic tools and therapeutic strategies to combat leptospirosis. Additionally, the identification of immunogenic regions within LDBPK_361420 could contribute to the design of novel vaccine candidates that provide protective immunity. Given the global burden of leptospirosis, the study of this protein represents a crucial step toward improving disease prevention and control measures.
